Literature DB >> 23083954

A laboratory study comparing the effect of ridge exposure using tissue punch versus mucoperiosteal flap on the formation of the implant-epithelial junction.

Cornelia K Mueller1, Michael Thorwarth, Jiang Chen, Stefan Schultze-Mosgau.   

Abstract

OBJECTIVE: The objective of the present study was to clarify the influence of the incision design at the time of implant placement on the consolidation of the implanto-epithelial junction. STUDY
DESIGN: Twelve minipigs were chosen for the study. Four weeks after premolar extraction in the maxilla, 4 BEGO Semados RI implants were inserted in each quadrant. Using a split-mouth design, the alveolar crest was exposed by a punch ("flapless surgery") on one side and by a crestal incision ("flap surgery") on the other side. Biopsies were obtained from the peri-implant soft tissue at weeks 1, 2, 4, and 12 postinsertion, respectively, and analyzed for the expression of integrin α(6)β(4) chain β(4) (ITGB4) and laminin 5 γ(2) chain (lamc2), 2 important marker molecules for the formation of the implanto-epithelial junction.
RESULTS: Following exposure of the alveolar crest by the punch technique, a significantly higher expression of ITGB4 was found at the 2- (P = .009), 4- (P = .001), and 12-week (P = .005) follow-up. Furthermore, the expression of lamc2 was significantly higher following punch exposure after 1 (P = .033), 2 (P = .041), 3 (P = .004), and 12 weeks (P = .002) of transmucosal implant healing.
CONCLUSIONS: The data of the present study indicate that flapless placement improved the formation of a sufficient implanto-epithelial junction.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23083954     DOI: 10.1016/j.tripleo.2011.08.019

Source DB:  PubMed          Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol


  1 in total

1.  A Pan-Cancer Analysis of the Oncogenic Role of Integrin Beta4 (ITGB4) in Human Tumors.

Authors:  Wenjie Huang; Li Fan; Yongmei Tang; Yinxiu Chi; Jingjing Li
Journal:  Int J Gen Med       Date:  2021-12-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.